JPH08104646A - Tyrosinase biosynthesis inhibitor and skin-beautifying agent mixed with the same - Google Patents
Tyrosinase biosynthesis inhibitor and skin-beautifying agent mixed with the sameInfo
- Publication number
- JPH08104646A JPH08104646A JP5314234A JP31423493A JPH08104646A JP H08104646 A JPH08104646 A JP H08104646A JP 5314234 A JP5314234 A JP 5314234A JP 31423493 A JP31423493 A JP 31423493A JP H08104646 A JPH08104646 A JP H08104646A
- Authority
- JP
- Japan
- Prior art keywords
- tyrosinase
- biosynthesis inhibitor
- extract
- tilia
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003425 Tyrosinase Human genes 0.000 title claims abstract description 33
- 108060008724 Tyrosinase Proteins 0.000 title claims abstract description 33
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 24
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 19
- 239000003112 inhibitor Substances 0.000 title claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 18
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 17
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 17
- 240000007313 Tilia cordata Species 0.000 claims abstract description 7
- 240000000073 Achillea millefolium Species 0.000 claims abstract description 4
- 235000007754 Achillea millefolium Nutrition 0.000 claims abstract description 4
- 235000015450 Tilia cordata Nutrition 0.000 claims abstract description 4
- 235000021525 Tilia platyphyllos Nutrition 0.000 claims abstract 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 39
- 230000002087 whitening effect Effects 0.000 claims description 35
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 9
- 244000292697 Polygonum aviculare Species 0.000 claims description 6
- 235000006386 Polygonum aviculare Nutrition 0.000 claims description 6
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 4
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 3
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 3
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 3
- 241000308663 Eupatorium fortunei Species 0.000 claims description 3
- 241000907897 Tilia Species 0.000 claims description 3
- 239000001138 artemisia absinthium Substances 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 240000001851 Artemisia dracunculus Species 0.000 claims 2
- 244000184734 Pyrus japonica Species 0.000 claims 2
- 235000010724 Wisteria floribunda Nutrition 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 13
- 208000003351 Melanosis Diseases 0.000 abstract description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract description 3
- 235000002168 Tilia europaea Nutrition 0.000 abstract description 2
- 240000006909 Tilia x europaea Species 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000000419 plant extract Substances 0.000 description 14
- 239000006071 cream Substances 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 229960005070 ascorbic acid Drugs 0.000 description 7
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 206010014970 Ephelides Diseases 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 230000008687 biosynthesis inhibition Effects 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 3
- 239000002035 hexane extract Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- JQQBXPCJFAKSPG-SVYIMCMUSA-N Geraniin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2[C@@H]3OC(=O)C=4C=C(O)C(O)=C5O[C@@]6(O)C(=O)C=C([C@@H](C5=4)C6(O)O)C(=O)O[C@H]4[C@@H]3OC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC[C@H]4O2)=C1 JQQBXPCJFAKSPG-SVYIMCMUSA-N 0.000 description 1
- 229920000061 Geraniin Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical class OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- GJMUCSXZXBCQRZ-UHFFFAOYSA-N geraniin Natural products Oc1cc(cc(O)c1O)C(=O)OC2OC3COC(=O)c4cc(O)c(O)c(O)c4c5cc(C(=O)C67OC3C(O6)C2OC(=O)c8cc(O)c(O)c9OC%10(O)C(C(=CC(=O)C%10(O)O)C7=O)c89)c(O)c(O)c5O GJMUCSXZXBCQRZ-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、特定の植物抽出物を配
合して成る、効果に優れ、且つ安全性及び安定性の高い
チロシナーゼ生合成阻害剤、及びこれを配合して成る美
白剤に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a tyrosinase biosynthesis inhibitor which is highly effective and highly safe, and which contains a specific plant extract, and a whitening agent which contains the same. .
【0002】[0002]
【従来の技術】従来より、皮膚の色黒,シミ,ソバカス
等を改善する上で、美白化粧料は非常に関心の深いもの
であり、これらにおいては、アスコルビン酸,グルタチ
オン,コロイドイオウ等が有効成分として配合されてき
た。2. Description of the Related Art Whitening cosmetics have been of great interest in improving the darkness of skin, spots, freckles, etc., and ascorbic acid, glutathione, colloidal sulfur, etc. are effective in them. It has been compounded as an ingredient.
【0003】また、種々の薬用植物抽出物や、植物由来
の没食子酸,ゲラニイン等を用いた例もある。さらに、
コウジ酸やグルコピラノシド誘導体であるアルブチンと
いった美白成分も最近使用されている。かかる美白成分
の中には、チロシナーゼ活性を阻害し、チロシンからド
ーパ〜ドーパキノン〜ドーパクロムの生成を阻害するこ
とにより、メラニン色素の生成を抑制して美白作用を発
揮するものがあることが明らかになってきた。There are also examples in which various medicinal plant extracts, plant-derived gallic acid, geraniin and the like are used. further,
Whitening ingredients such as kojic acid and arbutin, a glucopyranoside derivative, have also been used recently. It has become clear that among such whitening ingredients, there is one that inhibits tyrosinase activity and inhibits the production of dopa-dopaquinone-dopachrome from tyrosine, thereby suppressing the production of melanin pigment and exerting a whitening effect. Came.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、アスコ
ルビン酸は酸化されやすく不安定であり、グルタチオン
やコロイドイオウは、特有の異臭や沈澱が生じるという
欠点を有する。However, ascorbic acid is liable to be oxidized and is unstable, and glutathione and colloidal sulfur have a drawback that they have a peculiar offensive odor and precipitation.
【0005】また、従来の薬用植物抽出物は効果が今一
つ不十分であったり、品質が一定しないといった問題点
があった。さらに、コウジ酸等においても、その安定性
の維持等に配慮しなければならなかった。その他にも、
連用により副作用の発生するものもあった。さらに、チ
ロシナーゼ活性阻害作用を有する物質を美白剤として用
いる場合も、阻害活性は十分ではなく、効果を期待する
にはかなりの量を配合しなければならない場合が多かっ
た。In addition, the conventional medicinal plant extracts have problems that the effect is insufficient and the quality is not constant. Furthermore, it was necessary to consider maintaining the stability of kojic acid and the like. Besides,
In some cases, side effects occurred due to continuous use. Furthermore, even when a substance having a tyrosinase activity inhibitory effect is used as a whitening agent, the inhibitory activity was not sufficient, and in many cases, a considerable amount had to be added to expect an effect.
【0006】本発明は、かかる課題を解決するべく、チ
ロシナーゼが皮膚組織内にて生合成されるのを阻害し
て、チロシナーゼ量そのものを減少させることにより、
優れた美白作用を示すチロシナーゼ生合成阻害剤を提供
し、効果に優れ、且つ安定性及び安全性の高い美白剤と
して応用することを目的とする。In order to solve the above problems, the present invention inhibits the biosynthesis of tyrosinase in the skin tissue and reduces the amount of tyrosinase itself.
The purpose of the present invention is to provide a tyrosinase biosynthesis inhibitor exhibiting an excellent whitening effect, and to apply it as a whitening agent having excellent effects and high stability and safety.
【0007】[0007]
【課題を解決するための手段】チロシナーゼ生合成阻害
剤としては、なるべく少量の配合で優れた効果を発揮す
ることのできるものが望ましい。また、安全性上好まし
くない副作用を有さず、美白剤製剤中に配合したとき、
失活することなく、系の安定性に影響を及ぼさないもの
でなければならない。かかるチロシナーゼ生合成阻害作
用を有する物質のスクリーニングを行ったところ、われ
われは、特定の植物の抽出物中にきわめて優れたチロシ
ナーゼ生合成阻害活性を見い出した。As a tyrosinase biosynthesis inhibitor, it is desirable to use a tyrosinase biosynthesis inhibitor capable of exhibiting excellent effects even in a small amount. In addition, it has no adverse side effects on safety, and when incorporated into a whitening agent formulation,
It should not deactivate and should not affect the stability of the system. As a result of screening the substance having the tyrosinase biosynthesis inhibitory activity, we found an extremely excellent tyrosinase biosynthesis inhibitory activity in the extract of a specific plant.
【0008】すなわち本発明においては、イタドリ(Po
lygonum cuspidatum,Reynoutria japonica Houtt.),
カワラヨモギ(Artemisea capillaris),セイヨウノコ
ギリソウ(Achillea millefolium),フジバカマ(Eupa
torium fortunei),ナツボダイジュ(Tilia platyphyl
los),フユボダイジュ(Tilia cordata),セイヨウシ
ナノキ(Tilia europaea)の抽出物の1種又は2種以上
をチロシナーゼ生合成阻害剤として用いる。これらの抽
出物においては、皮膚刺激性,接触感作性といった皮膚
への悪影響もなく、また美白剤に配合したときも、チロ
シナーゼ生合成阻害活性の不活化は起こらず、品質も安
定していた。さらに、美白剤自体の安定性にも影響を及
ぼさなかった。That is, in the present invention, the knotweed ( Po
lygonum cuspidatum , Reynoutria japonica Houtt.),
Artemisea capillaris , Achillea millefolium , Fujibacama, Eupa
torium fortunei ), Natsubodaiju ( Tilia platyphyl)
los ), Fuyudaidai ( Tilia cordata ), and one or more kinds of extracts of Tilia europaea are used as tyrosinase biosynthesis inhibitors. These extracts had no adverse effects on the skin such as skin irritation and contact sensitization, and when incorporated into a whitening agent, the tyrosinase biosynthesis inhibitory activity was not inactivated and the quality was stable. . Furthermore, it did not affect the stability of the whitening agent itself.
【0009】本発明において使用する上記植物の抽出物
は、一般的には乾燥或いは生植物を細切したもの10〜
30部に、エタノール,酢酸エチル,アセトン,ヘキサ
ン等の有機溶媒もしくはこれらの有機溶媒の混合物、又
は水と上記有機溶媒との混合物あるいは水100部を加
えて、室温にて約1週間攪拌しながら抽出を行った後、
ろ過して、ろ液を採取して得る。アセトンやヘキサンな
どの揮発性溶媒を用いた場合には、溶媒を留去し、残留
物を乾燥して得ることもできる。イタドリ(Polygonum
cuspidatum,Reynoutria japonica Houtt.)については
ヘキサン,酢酸エチル又は水による抽出物が、またカワ
ラヨモギ(Artemisea capillaris)については、酢酸エ
チル又はアセトン抽出物が特に高い活性を示した。The above-mentioned plant extracts used in the present invention are generally dried or shredded fresh plants.
To 30 parts of an organic solvent such as ethanol, ethyl acetate, acetone, hexane or a mixture of these organic solvents, or a mixture of water and the above organic solvent or 100 parts of water is added, and the mixture is stirred at room temperature for about 1 week. After performing the extraction
It is obtained by filtering and collecting the filtrate. When a volatile solvent such as acetone or hexane is used, the solvent can be distilled off and the residue can be dried. Knotweed ( Polygonum
cuspidatum , Reynoutria japonica Houtt.) with hexane, ethyl acetate or water extract, and with Artemisea capillaris , ethyl acetate or acetone extract showed particularly high activity.
【0010】本発明において、上記植物抽出物より成る
チロシナーゼ生合成阻害剤の美白剤への配合量は0.0
01〜20重量%が適当である。配合量が0.001重
量%以下であると十分な美白効果が得られないが、美白
作用がかなり強いため、あまり多量に配合する必要もな
く、20重量%を超えると美白剤の安定性等に影響を及
ぼすこともある。In the present invention, the amount of the tyrosinase biosynthesis inhibitor comprising the above plant extract added to the whitening agent is 0.0.
01 to 20% by weight is suitable. If the blending amount is 0.001% by weight or less, a sufficient whitening effect cannot be obtained, but since the whitening effect is quite strong, it is not necessary to blend a too large amount, and if it exceeds 20% by weight, the stability of the whitening agent, etc. Can also affect.
【0011】本発明においては、上記のチロシナーゼ生
合成阻害剤を配合して美白剤を提供し得るが、美白剤と
しては、ローション,乳剤,クリーム,軟膏等の形態と
することができる。またさらに、柔軟性化粧水,収斂性
化粧水,洗浄用化粧水等の化粧水類、エモリエントクリ
ーム,モイスチュアクリーム,マッサージクリーム,ク
レンジングクリーム,メイクアップクリーム等のクリー
ム類、エモリエント乳液,モイスチュア乳液,ナリシン
グ乳液,クレンジング乳液等の乳液類、ゼリー状パッ
ク,ピールオフパック,粉末状パック等のパック類、及
び洗顔料類といった種々の製剤形態の美白化粧料として
も提供することができる。In the present invention, the above-mentioned tyrosinase biosynthesis inhibitor may be blended to provide a whitening agent. The whitening agent may be in the form of lotion, emulsion, cream, ointment or the like. Furthermore, softening lotion, astringent lotion, lotion such as cleaning lotion, emollient cream, moisturizing cream, massage cream, cleansing cream, cream such as makeup cream, emollient emulsion, moisturizing emulsion, nourishing It can also be provided as a whitening cosmetic in various formulation forms such as milky lotion, milky lotion such as cleansing milky lotion, packs such as jelly pack, peel-off pack, powdery pack, and face wash.
【0012】[0012]
【作用】本発明に係るチロシナーゼ生合成阻害剤の作用
について評価を行った。評価は次のようにして行った。The action of the tyrosinase biosynthesis inhibitor according to the present invention was evaluated. The evaluation was performed as follows.
【0013】まず、乾燥した各植物細片10gを50重
量%エタノール100ml中に入れ、室温で1週間抽出
を行った。この植物抽出物を精製水にて100倍希釈し
て試料溶液を調製した。次に、この試料溶液を終濃度5
00μg/mlとなるようにマウス由来のメラノーマ細
胞系に添加して3日間培養した後、細胞中のチロシナー
ゼ活性を測定した。培養は細胞数50,000程度から
行った。First, 10 g of each dried plant strip was placed in 100 ml of 50% by weight ethanol and extracted at room temperature for 1 week. This plant extract was diluted 100-fold with purified water to prepare a sample solution. Next, this sample solution
The tyrosinase activity in the cells was measured after the cells were added to a mouse-derived melanoma cell line at a concentration of 00 μg / ml and cultured for 3 days. Culturing was performed from about 50,000 cells.
【0014】細胞中のチロシナーゼ活性は、1/15M
リン酸緩衝液(pH6.8)2mlに1.0重量%ドー
パ水溶液0.5ml及び培養細胞液0.5mlを混合
し、37℃にて1時間インキュベートして酵素反応を行
わせた後、405nmにおける吸光度(As)により測
定した。対照として、試料溶液の代わりに0.5重量%
エタノールを同様に添加して培養した細胞液を用いた系
において同様に酵素反応を行わせ、その場合における吸
光度(Ab)を測定した。チロシナーゼ生合成阻害率
は、数1により求めた。The tyrosinase activity in cells is 1/15 M
2 ml of phosphate buffer (pH 6.8) was mixed with 0.5 ml of 1.0 wt% dopa aqueous solution and 0.5 ml of culture cell solution, incubated at 37 ° C. for 1 hour to carry out an enzymatic reaction, and then 405 nm It was measured by the absorbance (As) at. As a control, 0.5% by weight instead of the sample solution
Similarly, an enzyme reaction was carried out in a system using a cell solution obtained by culturing by adding ethanol in the same manner, and the absorbance (Ab) in that case was measured. The tyrosinase biosynthesis inhibition rate was calculated by the equation 1.
【数1】 [Equation 1]
【0015】また、イタドリ(Polygonum cuspidatum,
Reynoutria japonica Houtt.)についてはヘキサン,酢
酸エチル又は精製水によりそれぞれ抽出し、ヘキサン抽
出物についてはヘキサンを留去し、残留物をエタノール
に溶解した。カワラヨモギ(Artemisea capillaris)に
ついても、酢酸エチル又はアセトンによりそれぞれ抽出
し、アセトン抽出物についてはアセトンを留去後、残留
物をエタノールに溶解した。これらを精製水にて100
倍希釈して試料溶液とし、上記の方法によりチロシナー
ゼ生合成阻害率を測定した。この際、ヘキサン抽出物に
ついては1.0重量%エタノール、酢酸エチル抽出物に
ついては1.0重量%酢酸エチル、精製水抽出物につい
ては精製水を対照とした。Also, the Japanese knotweed ( Polygonum cuspidatum ,
Reynoutria japonica Houtt.) Was extracted with hexane, ethyl acetate or purified water, and the hexane extract was distilled to remove hexane, and the residue was dissolved in ethanol. The sagebrush ( Artemisea capillaris ) was also extracted with ethyl acetate or acetone, and the acetone extract was distilled off, and the residue was dissolved in ethanol. 100 with purified water
The sample solution was double-diluted, and the tyrosinase biosynthesis inhibition rate was measured by the above method. At this time, 1.0 wt% ethanol was used as a control for the hexane extract, 1.0 wt% ethyl acetate was used for the ethyl acetate extract, and purified water was used as a control for the purified water extract.
【0016】測定結果を表1に示した。表1より明らか
なように、本発明で使用する植物抽出物は、いずれも有
意に高いチロシナーゼ生合成阻害率を示していた。中で
も、イタドリ(Polygonum cuspidatum,Reynoutria jap
onica Houtt.)についてはヘキサン,酢酸エチル,精製
水による抽出物において、またカワラヨモギ(Artemise
a capillaris)については、酢酸エチル及びアセトンに
よる抽出物において阻害率が特に高かった。従って、こ
れらの植物抽出物により、チロシンからメラニンが生成
されるのを抑制し、有効な美白効果を発揮させることが
できる。The measurement results are shown in Table 1. As is clear from Table 1, all the plant extracts used in the present invention showed a significantly high tyrosinase biosynthesis inhibition rate. Among them, Japanese knotweed ( Polygonum cuspidatum , Reynoutria jap
onica Houtt.) in extracts with hexane, ethyl acetate, purified water, and wormwood ( Artemise).
a capillaris ), the inhibition rate was particularly high in the extracts with ethyl acetate and acetone. Therefore, these plant extracts can suppress the production of melanin from tyrosine and exhibit an effective whitening effect.
【表1】 [Table 1]
【0017】[0017]
【実施例】次に、本発明を実施例によりさらに詳細に説
明する。EXAMPLES Next, the present invention will be described in more detail by way of examples.
【0018】実施例1〜実施例4は、本発明に係る美白
クリームである。処方を表2に示す。表2中、(1)〜(7)
を75℃に加熱溶解し、これに75℃に加熱溶解した(1
0)〜(13)を加えて乳化し、冷却して50℃にて(8),(9)
を添加し、さらに冷却して美白クリームとする。その
際、(9)の植物抽出物のうち、ヘキサン抽出物及び酢酸
エチル抽出物については、溶媒を留去した後、残留物を
エタノールに溶解又は分散させて用いた。また、植物抽
出物をアスコルビン酸に代替し、(13)の一部に溶解して
乳化後に添加したものを比較例1とした。Examples 1 to 4 are whitening creams according to the present invention. The prescription is shown in Table 2. In Table 2, (1) to (7)
Was melted by heating to 75 ° C, and this was heated and melted at 75 ° C (1
Add (0) to (13) to emulsify, cool and (8), (9) at 50 ° C.
Is added and the mixture is further cooled to obtain a whitening cream. At that time, of the plant extract of (9), the hexane extract and the ethyl acetate extract were used after the solvent was distilled off and the residue was dissolved or dispersed in ethanol. Further, Comparative Example 1 was prepared by substituting the plant extract with ascorbic acid, dissolving it in a part of (13) and adding it after emulsification.
【表2】 [Table 2]
【0019】実施例5〜実施例7は、本発明に係る美白
用乳剤型軟膏である。処方を表3に示す。表3中、(1)
〜(4)の油相成分を混合,溶解して均一とし、75℃に
加熱したものを、(5)を(7)に溶解して75℃に加熱した
ところに加えて乳化し、冷却後50℃にて(6)を添加,
混合する。この場合も、(6)の植物抽出物のうち、酢酸
エチル及びアセトン抽出物については溶媒を留去し、エ
タノールに溶解又は分散させて用いた。また、植物抽出
物をアスコルビン酸に代替して、(7)の一部に溶解して
乳化後に添加したものを比較例2とした。Examples 5 to 7 are whitening emulsion type ointments according to the present invention. The prescription is shown in Table 3. In Table 3, (1)
~ Mix the oil phase components of (4), dissolve and homogenize, heat to 75 ℃, add (5) to (7) and heat to 75 ℃, add to emulsify, and after cooling Add (6) at 50 ℃,
Mix. In this case as well, of the plant extract of (6), the ethyl acetate and acetone extracts were used by distilling off the solvent and dissolving or dispersing in ethanol. In addition, as a comparative example 2, a plant extract was replaced with ascorbic acid and dissolved in a part of (7) and added after emulsification.
【表3】 [Table 3]
【0020】実施例8及び実施例9は、本発明に係る美
白乳液である。処方を表4に示す。表4中、(1)〜(6)を
75℃に加熱溶解し、これに75℃に加熱溶解した(9)
〜(13)を添加して乳化し、冷却して50℃にて(7),(8)
を添加し、さらに冷却して美白乳液とする。この場合、
(8)の植物抽出物はエタノールによる抽出物を用いた。
また、これをアスコルビン酸に代替し、(13)の一部に溶
解して乳化後に添加したものを比較例3とした。Examples 8 and 9 are whitening emulsions according to the present invention. The prescription is shown in Table 4. In Table 4, (1) to (6) were heated and dissolved at 75 ° C, and then heated and dissolved at 75 ° C (9).
~ (13) is added to emulsify, cool and at 50 ℃ (7), (8)
Is added and further cooled to obtain a whitening emulsion. in this case,
As the plant extract in (8), an ethanol extract was used.
Further, this was replaced with ascorbic acid, dissolved in a part of (13), and added after emulsification, to make Comparative Example 3.
【表4】 [Table 4]
【0021】実施例10は、本発明に係る美白ローショ
ンである。処方を表5に示す。表5中、(1)〜(12)の各
成分を混合,溶解して均一化する。この場合も、(6)〜
(8)の植物抽出物はエタノールによる抽出物を用いた。
また、(6)〜(8)をアスコルビン酸3.0重量%に代替し
たものを比較例4とした。Example 10 is a whitening lotion according to the present invention. The prescription is shown in Table 5. In Table 5, the components (1) to (12) are mixed and dissolved to homogenize. Also in this case, (6) ~
As the plant extract in (8), an ethanol extract was used.
Further, Comparative Example 4 was prepared by substituting (6) to (8) with 3.0% by weight of ascorbic acid.
【表5】 [Table 5]
【0022】上記の実施例及び比較例について、使用試
験を行って美白効果を評価した。使用試験は、シミ,ソ
バカスの気になる30〜40才の女性パネラー20名ず
つを1群とし、各群について実施例及び比較例の各試料
をブラインドにて使用させて行った。毎日朝と夜の2
回、洗顔後に試料の適量を顔面に塗布させ、2月間使用
を継続させた。美白効果は、使用試験終了後の顔面のシ
ミ,ソバカスの状態を観察して評価した。結果を表6に
示す。A use test was conducted on the above-mentioned Examples and Comparative Examples to evaluate the whitening effect. The use test was carried out by using 20 female panelists aged 30 to 40 years old who are concerned about stains and freckles as one group, and using each sample of Examples and Comparative Examples in a blind for each group. Every morning and night 2
After washing and washing the face, an appropriate amount of the sample was applied to the face and continued to be used for 2 months. The whitening effect was evaluated by observing the condition of facial spots and freckles after the use test. The results are shown in Table 6.
【表6】 [Table 6]
【0023】表6において、実施例を使用した群では、
パネラーの50%以上においてシミ,ソバカスの明らか
な改善を認めており、残りのパネラーにおいても改善傾
向が認められた。シミ,ソバカスの改善における有効率
はいずれの実施例についても100%であった。特に、
チロシナーゼ生合成阻害率の高い抽出物を配合した実施
例2〜実施例4、実施例6及び実施例7使用群では、シ
ミ,ソバカスが明らかに改善されたパネラーの割合が高
く、実施例4においては全員について明らかな改善を認
めていた。これに対し、各比較例使用群では、アスコル
ビン酸の安定性が悪いことも影響し、良くても50%の
パネラーにおいて改善傾向を認めたにとどまった。In Table 6, in the group using the examples,
In 50% or more of the panelists, clear improvement of spots and freckles was observed, and the remaining panelists also showed an improvement tendency. The effective rate for improving spots and freckles was 100% in all Examples. In particular,
In the use groups of Examples 2 to 4, Example 6, and Example 7 in which the extract having a high tyrosinase biosynthesis inhibition rate was blended, the proportion of panelists in which spots and freckles were obviously improved was high, and in Example 4, Acknowledged a clear improvement for all. On the other hand, in each of the groups used in Comparative Examples, the poor stability of ascorbic acid also had an effect, and an improvement tendency was observed only in 50% of the panelists at best.
【0024】さらに、上記の使用試験期間において、い
ずれの実施例を使用した群においても、痛み,かゆみ等
の皮膚刺激やアレルギー反応等の皮膚障害を訴えたパネ
ラーはいなかった。また、配合成分の沈降,変質等の美
白剤の品質の低下もみられなかった。Further, no panelists complained of skin irritation such as pain and itch or skin disorder such as allergic reaction in any of the groups used in the above-mentioned use test period. In addition, the quality of the whitening agent such as sedimentation and deterioration of the blended components was not observed.
【0025】[0025]
【発明の効果】以上のように、本発明により、少量の添
加で有効にチロシナーゼの生合成を阻害し得るチロシナ
ーゼ生合成阻害剤を得ることができ、これを配合するこ
とにより、優れた美白効果を示し、且つ安定性及び安全
性も良好な美白剤を提供することができた。Industrial Applicability As described above, according to the present invention, a tyrosinase biosynthesis inhibitor capable of effectively inhibiting the biosynthesis of tyrosinase can be obtained by adding a small amount thereof, and by adding this, an excellent whitening effect can be obtained. And a whitening agent having good stability and safety.
Claims (5)
outria japonica Houtt.),カワラヨモギ(Artemisea
capillaris),セイヨウノコギリソウ(Achillea mille
folium),フジバカマ(Eupatorium fortunei),ナツ
ボダイジュ(Tilia platyphyllos),フユボダイジュ
(Tilia cordata),セイヨウシナノキ(Tilia europae
a)の抽出物の1種又は2種以上を配合することを特徴
とする、チロシナーゼ生合成阻害剤。1. A knotweed ( Polygonum cuspidatum , Reyn
outria japonica Houtt., Artemisea
capillaris ), Achillea mille
folium ), Fuji Bacama ( Eupatorium fortunei ), Natsubodaiju ( Tilia platyphyllos ), Fuyubodaiju ( Tilia cordata ), Tilia europae
A tyrosinase biosynthesis inhibitor, comprising one or more kinds of the extract of a ).
outria japonica Houtt.),カワラヨモギ(Artemisea
capillaris),セイヨウノコギリソウ(Achillea mille
folium),フジバカマ(Eupatorium fortunei),ナツ
ボダイジュ(Tilia platyphyllos),フユボダイジュ
(Tilia cordata),セイヨウシナノキ(Tilia europae
a)の抽出物の1種又は2種以上を、チロシナーゼ生合
成阻害剤として配合することを特徴とする、美白剤。2. A knotweed ( Polygonum cuspidatum , Reyn
outria japonica Houtt., Artemisea
capillaris ), Achillea mille
folium ), Fuji Bacama ( Eupatorium fortunei ), Natsubodaiju ( Tilia platyphyllos ), Fuyubodaiju ( Tilia cordata ), Tilia europae
A whitening agent comprising one or more kinds of the extract of a ) as a tyrosinase biosynthesis inhibitor.
outria japonica Houtt.)のヘキサン,酢酸エチル,又
は水による抽出物、及び/又はカワラヨモギ(Artemise
a capillaris)の酢酸エチル又はアセトン抽出物を配合
することを特徴とする、チロシナーゼ生合成阻害剤。3. A knotweed ( Polygonum cuspidatum , Reyn
extract of outria japonica Houtt.) with hexane, ethyl acetate, or water, and / or wormwood ( Artemise)
a capillaris ) and an ethyl acetate or acetone extract thereof.
outria japonica Houtt.)のヘキサン,酢酸エチル,又
は水による抽出物、及び/又はカワラヨモギ(Artemise
a capillaris)の酢酸エチル又はアセトン抽出物を、チ
ロシナーゼ生合成阻害剤として配合することを特徴とす
る、美白剤。4. A knotweed ( Polygonum cuspidatum , Reyn
extract of outria japonica Houtt.) with hexane, ethyl acetate, or water, and / or wormwood ( Artemise)
a whitening agent, characterized by comprising an ethyl acetate or acetone extract of a capillaris ) as a tyrosinase biosynthesis inhibitor.
する、請求項2又は請求項4に記載の美白剤。5. The whitening agent according to claim 2, wherein the whitening agent is a whitening cosmetic composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31423493A JP3660692B2 (en) | 1993-11-18 | 1993-11-18 | Tyrosinase biosynthesis inhibitor and whitening agent comprising the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31423493A JP3660692B2 (en) | 1993-11-18 | 1993-11-18 | Tyrosinase biosynthesis inhibitor and whitening agent comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH08104646A true JPH08104646A (en) | 1996-04-23 |
| JP3660692B2 JP3660692B2 (en) | 2005-06-15 |
Family
ID=18050904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP31423493A Expired - Lifetime JP3660692B2 (en) | 1993-11-18 | 1993-11-18 | Tyrosinase biosynthesis inhibitor and whitening agent comprising the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3660692B2 (en) |
Cited By (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10203954A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Antimicrobial low-irritating cosmetic |
| JPH10203991A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Preparation for external use for skin |
| JPH10203955A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Antimicrobial low-irritating cosmetic |
| JPH11349435A (en) * | 1998-06-03 | 1999-12-21 | Noevir Co Ltd | External preparation for skin effective for preventing and improving pigmentation symptoms caused by ultraviolet rays |
| WO2000071092A1 (en) * | 1999-05-21 | 2000-11-30 | Lg Household & Health Care Ltd. | Skin whitener |
| JP2001288052A (en) * | 2000-04-10 | 2001-10-16 | Maruzen Pharmaceut Co Ltd | Tyrosinase activity promoter and gray hair improving agent |
| JP2002114668A (en) * | 2000-10-11 | 2002-04-16 | Noevir Co Ltd | Skin care preparation |
| JP2002179523A (en) * | 2000-12-15 | 2002-06-26 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing extract of swine placenta |
| JP2002187812A (en) * | 2000-12-20 | 2002-07-05 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing horse placenta extract |
| JP2002284626A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | External skin preparation |
| JP2002284625A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | Cosmetics |
| US6521267B1 (en) | 1998-06-08 | 2003-02-18 | Fytokem Prtoducts, Inc. | Tyrosinase inhibitors from plants |
| JP2003137762A (en) * | 2001-11-01 | 2003-05-14 | Noevir Co Ltd | Skin care preparation |
| JP2004043514A (en) * | 2003-11-14 | 2004-02-12 | Noevir Co Ltd | Inhibitor of endothelin-1 |
| JP2005023042A (en) * | 2003-07-04 | 2005-01-27 | Noevir Co Ltd | External preparation for skin |
| KR100453217B1 (en) * | 1998-05-15 | 2005-07-07 | 주식회사 엘지생활건강 | Skin whitener |
| JP2006124355A (en) * | 2004-11-01 | 2006-05-18 | Ichimaru Pharcos Co Ltd | Phagocytosis inhibitor |
| JP2007008888A (en) * | 2005-07-01 | 2007-01-18 | Nicca Chemical Co Ltd | Melanin synthesis promoter and topical skin preparation |
| CN1324021C (en) * | 2002-12-03 | 2007-07-04 | 宝丽化学工业有限公司 | Inhibitor of dendrite elongation of melanocytes and skin external preparation containing the same |
| JP2007182420A (en) * | 2005-12-30 | 2007-07-19 | Ind Technol Res Inst | Herbal composition for suppressing free radicals and health food containing the herbal composition |
| JP2009046503A (en) * | 2008-10-06 | 2009-03-05 | Pola Chem Ind Inc | Method for production of melanocyte dendrite growth-suppressing agent |
| WO2009113446A1 (en) * | 2008-03-11 | 2009-09-17 | 株式会社資生堂 | Skin whitening method and screening method for factors for skin wrinkle formation suppression and/or removal |
| US7795300B2 (en) | 2003-12-15 | 2010-09-14 | Kuraray Co., Ltd. | External preparation for skin |
| JP2010275227A (en) * | 2009-05-28 | 2010-12-09 | Kose Corp | Whitening agent, whitening cosmetic, and method for producing whitening agent |
| US8980336B2 (en) | 2005-12-30 | 2015-03-17 | Industrial Technology Research Institute | Method for inhibiting free radicals |
| JP2018535250A (en) * | 2015-10-01 | 2018-11-29 | フォトダイナミック インコーポレイテッド | POLYGONUM CUSPIDATUM extracts and their use as photodynamic inactivators |
| CN114469799A (en) * | 2021-11-02 | 2022-05-13 | 广州古泉生物科技有限公司 | Skin care cream and preparation method thereof |
| US20220218592A1 (en) * | 2021-01-14 | 2022-07-14 | Doncab | Plant derived active ingredient comprising plant extracts |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04300812A (en) * | 1991-03-29 | 1992-10-23 | Maruzen Pharmaceut Co Ltd | Costmetic |
| JPH04342519A (en) * | 1990-10-11 | 1992-11-30 | Kose Corp | Skin cosmetic |
| JPH05139950A (en) * | 1991-11-26 | 1993-06-08 | Pola Chem Ind Inc | Cosmetic |
| JPH05294819A (en) * | 1992-04-15 | 1993-11-09 | Noevir Co Ltd | Beautifying cosmetic |
-
1993
- 1993-11-18 JP JP31423493A patent/JP3660692B2/en not_active Expired - Lifetime
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04342519A (en) * | 1990-10-11 | 1992-11-30 | Kose Corp | Skin cosmetic |
| JPH04300812A (en) * | 1991-03-29 | 1992-10-23 | Maruzen Pharmaceut Co Ltd | Costmetic |
| JPH05139950A (en) * | 1991-11-26 | 1993-06-08 | Pola Chem Ind Inc | Cosmetic |
| JPH05294819A (en) * | 1992-04-15 | 1993-11-09 | Noevir Co Ltd | Beautifying cosmetic |
Cited By (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10203991A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Preparation for external use for skin |
| JPH10203955A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Antimicrobial low-irritating cosmetic |
| JPH10203954A (en) * | 1997-01-20 | 1998-08-04 | Noevir Co Ltd | Antimicrobial low-irritating cosmetic |
| KR100453217B1 (en) * | 1998-05-15 | 2005-07-07 | 주식회사 엘지생활건강 | Skin whitener |
| JPH11349435A (en) * | 1998-06-03 | 1999-12-21 | Noevir Co Ltd | External preparation for skin effective for preventing and improving pigmentation symptoms caused by ultraviolet rays |
| US6521267B1 (en) | 1998-06-08 | 2003-02-18 | Fytokem Prtoducts, Inc. | Tyrosinase inhibitors from plants |
| WO2000071092A1 (en) * | 1999-05-21 | 2000-11-30 | Lg Household & Health Care Ltd. | Skin whitener |
| JP2001288052A (en) * | 2000-04-10 | 2001-10-16 | Maruzen Pharmaceut Co Ltd | Tyrosinase activity promoter and gray hair improving agent |
| JP2002114668A (en) * | 2000-10-11 | 2002-04-16 | Noevir Co Ltd | Skin care preparation |
| JP2002179523A (en) * | 2000-12-15 | 2002-06-26 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing extract of swine placenta |
| JP2002187812A (en) * | 2000-12-20 | 2002-07-05 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing horse placenta extract |
| JP2002284625A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | Cosmetics |
| JP2002284626A (en) * | 2001-03-23 | 2002-10-03 | Nippon Hypox Lab Inc | External skin preparation |
| JP2003137762A (en) * | 2001-11-01 | 2003-05-14 | Noevir Co Ltd | Skin care preparation |
| US8183283B2 (en) | 2002-12-03 | 2012-05-22 | Pola Chemical Industries Inc. | Dendrite elongation inhibitor for melanocyte and skin preparation for external use containing the same |
| CN1324021C (en) * | 2002-12-03 | 2007-07-04 | 宝丽化学工业有限公司 | Inhibitor of dendrite elongation of melanocytes and skin external preparation containing the same |
| JP2005023042A (en) * | 2003-07-04 | 2005-01-27 | Noevir Co Ltd | External preparation for skin |
| JP2004043514A (en) * | 2003-11-14 | 2004-02-12 | Noevir Co Ltd | Inhibitor of endothelin-1 |
| US7795300B2 (en) | 2003-12-15 | 2010-09-14 | Kuraray Co., Ltd. | External preparation for skin |
| JP2006124355A (en) * | 2004-11-01 | 2006-05-18 | Ichimaru Pharcos Co Ltd | Phagocytosis inhibitor |
| JP2007008888A (en) * | 2005-07-01 | 2007-01-18 | Nicca Chemical Co Ltd | Melanin synthesis promoter and topical skin preparation |
| US8980336B2 (en) | 2005-12-30 | 2015-03-17 | Industrial Technology Research Institute | Method for inhibiting free radicals |
| JP2007182420A (en) * | 2005-12-30 | 2007-07-19 | Ind Technol Res Inst | Herbal composition for suppressing free radicals and health food containing the herbal composition |
| WO2009113446A1 (en) * | 2008-03-11 | 2009-09-17 | 株式会社資生堂 | Skin whitening method and screening method for factors for skin wrinkle formation suppression and/or removal |
| CN101969915A (en) * | 2008-03-11 | 2011-02-09 | 株式会社资生堂 | Skin whitening method and screening method for factors for skin wrinkle formation suppression and/or removal |
| JPWO2009113446A1 (en) * | 2008-03-11 | 2011-07-21 | 株式会社 資生堂 | Skin whitening method and screening method for skin spot formation inhibition and / or removal factor |
| JP2009046503A (en) * | 2008-10-06 | 2009-03-05 | Pola Chem Ind Inc | Method for production of melanocyte dendrite growth-suppressing agent |
| JP2010275227A (en) * | 2009-05-28 | 2010-12-09 | Kose Corp | Whitening agent, whitening cosmetic, and method for producing whitening agent |
| JP2018535250A (en) * | 2015-10-01 | 2018-11-29 | フォトダイナミック インコーポレイテッド | POLYGONUM CUSPIDATUM extracts and their use as photodynamic inactivators |
| US11660323B2 (en) | 2015-10-01 | 2023-05-30 | PhotoDynamic Inc. | Use of Polygonum cuspidatum extracts as photodynamic antimicrobial agents |
| US20220218592A1 (en) * | 2021-01-14 | 2022-07-14 | Doncab | Plant derived active ingredient comprising plant extracts |
| US11684563B2 (en) * | 2021-01-14 | 2023-06-27 | Doncab | Plant derived active ingredient comprising plant extracts |
| CN114469799A (en) * | 2021-11-02 | 2022-05-13 | 广州古泉生物科技有限公司 | Skin care cream and preparation method thereof |
| CN114469799B (en) * | 2021-11-02 | 2023-08-18 | 广州古泉生物科技有限公司 | Skin care cream and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3660692B2 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08104646A (en) | Tyrosinase biosynthesis inhibitor and skin-beautifying agent mixed with the same | |
| JPH06199647A (en) | Skin beautifying cosmetic | |
| JP3481386B2 (en) | Skin whitening preparation for external use | |
| JPH0930946A (en) | Beautifying and whitening dermal preparation for external use | |
| JP3410870B2 (en) | External preparation for skin | |
| JPH05139951A (en) | Face powder | |
| JPH0812561A (en) | Beautifying and whitening skin preparation for external use | |
| JPH0987136A (en) | Dermal preparation for external use | |
| JP3082994B2 (en) | Whitening cosmetics | |
| JPH1029927A (en) | Antiaging agent | |
| JPH0925212A (en) | Skin preparation for external use | |
| JPH10251155A (en) | Protease inhibitor | |
| JPH0925213A (en) | Skin preparation for external use | |
| JPH0930945A (en) | Dermal preparation for external use | |
| JP3693243B2 (en) | Whitening cosmetics | |
| JPH0812549A (en) | Skin external preparation | |
| JP3747192B2 (en) | Topical skin preparation | |
| JPH0971522A (en) | Whitening skin external preparation | |
| JPH0812552A (en) | Skin external preparation | |
| JPH0930948A (en) | Beautifying and whitening dermal preparation for external use | |
| JP2006298814A (en) | Skin preparation for acne | |
| JPH05271045A (en) | Cosmetic | |
| JPH04235113A (en) | Skin-beautifying cosmetic | |
| JPH0920635A (en) | Whitening skin preparation for external use | |
| JPH0812564A (en) | Skin external preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040816 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041014 |
|
| RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7421 Effective date: 20041014 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20041015 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041210 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050208 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050302 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050318 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080325 Year of fee payment: 3 |
|
| RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D05 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080325 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090325 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100325 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100325 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110325 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130325 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140325 Year of fee payment: 9 |
|
| EXPY | Cancellation because of completion of term |